Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
3.75M
-
Shares change
-
+141K
-
Total reported value, excl. options
-
$17.6M
-
Value change
-
-$1.87M
-
Put/Call ratio
-
1.64
-
Number of buys
-
23
-
Number of sells
-
-22
-
Price
-
$4.70
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2017
68 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2017.
XBiotech Inc. - Common Shares, no par value (XBIT) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.75M shares
of 30.8M outstanding shares and own 12.18% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.44M shares), VANGUARD GROUP INC (786K shares), STATE STREET CORP (310K shares), NORTHERN TRUST CORP (236K shares), GEODE CAPITAL MANAGEMENT, LLC (163K shares), GOLDMAN SACHS GROUP INC (80.3K shares), Bank of New York Mellon Corp (73.5K shares), A.R.T. Advisors, LLC (50.3K shares), TIAA CREF INVESTMENT MANAGEMENT LLC (43.4K shares), and ALLIANCEBERNSTEIN L.P. (42.8K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.